126 related articles for article (PubMed ID: 17474354)
1. Cutaneous T-cell lymphoma: molecular and cytogenetic findings.
Sterry W
Oncology (Williston Park); 2007 Feb; 21(2 Suppl 1):13-7. PubMed ID: 17474354
[TBL] [Abstract][Full Text] [Related]
2. Primary cutaneous T-cell lymphomas show a deletion or translocation affecting NAV3, the human UNC-53 homologue.
Karenko L; Hahtola S; Päivinen S; Karhu R; Syrjä S; Kähkönen M; Nedoszytko B; Kytölä S; Zhou Y; Blazevic V; Pesonen M; Nevala H; Nupponen N; Sihto H; Krebs I; Poustka A; Roszkiewicz J; Saksela K; Peterson P; Visakorpi T; Ranki A
Cancer Res; 2005 Sep; 65(18):8101-10. PubMed ID: 16166283
[TBL] [Abstract][Full Text] [Related]
3. Chromosomal imbalances: a hallmark of tumour relapse in primary cutaneous CD30+ T-cell lymphoma.
Prochazkova M; Chevret E; Beylot-Barry M; Sobotka J; Vergier B; Delaunay M; Turmo M; Ferrer J; Kuglik P; Merlio JP
J Pathol; 2003 Nov; 201(3):421-9. PubMed ID: 14595754
[TBL] [Abstract][Full Text] [Related]
4. Primary cutaneous follicle center lymphoma of the arm with a novel chromosomal translocation t(12;21)(q13;q22): a case report.
Jelic TM; Berry PK; Jubelirer SJ; Plumley L; Hartel PH; Estalilla OC; Chang HH
Am J Hematol; 2006 Jun; 81(6):448-53. PubMed ID: 16680749
[TBL] [Abstract][Full Text] [Related]
5. Clinicopathological characterization and genomic aberrations in subcutaneous panniculitis-like T-cell lymphoma.
Hahtola S; Burghart E; Jeskanen L; Karenko L; Abdel-Rahman WM; Polzer B; Kajanti M; Peltomäki P; Pettersson T; Klein CA; Ranki A
J Invest Dermatol; 2008 Sep; 128(9):2304-9. PubMed ID: 18337827
[TBL] [Abstract][Full Text] [Related]
6. Cytogenetic findings in cell lines from cutaneous T-cell lymphoma.
Kaltoft K; Hansen BH; Thestrup-Pedersen K
Dermatol Clin; 1994 Apr; 12(2):295-304. PubMed ID: 8045039
[TBL] [Abstract][Full Text] [Related]
7. Genomic aberrations and survival in cutaneous T cell lymphomas.
Fischer TC; Gellrich S; Muche JM; Sherev T; Audring H; Neitzel H; Walden P; Sterry W; Tönnies H
J Invest Dermatol; 2004 Mar; 122(3):579-86. PubMed ID: 15086538
[TBL] [Abstract][Full Text] [Related]
8. Molecular markers associated with clinical response to bexarotene therapy in cutaneous T-cell lymphoma.
Ranki A; Väkevä L; Sipilä L; Krohn K
Acta Derm Venereol; 2011 Sep; 91(5):568-73. PubMed ID: 21547336
[TBL] [Abstract][Full Text] [Related]
9. Overexpression of c-myb in leukaemic and non-leukaemic variants of cutaneous T-cell lymphoma.
Poenitz N; Simon-Ackermann J; Gratchev A; Qadoumi M; Klemke CD; Stadler R; Kremer A; Radenhausen M; Henke U; Assaf C; Utikal J; Goerdt S; Dippel E
Dermatology; 2005; 211(2):84-92. PubMed ID: 16088151
[TBL] [Abstract][Full Text] [Related]
10. Primary cutaneous T-cell lymphomas do not show specific NAV3 gene deletion or translocation.
Marty M; Prochazkova M; Laharanne E; Chevret E; Longy M; Jouary T; Vergier B; Beylot-Barry M; Merlio JP
J Invest Dermatol; 2008 Oct; 128(10):2458-66. PubMed ID: 18509363
[TBL] [Abstract][Full Text] [Related]
11. High expression of Dicer reveals a negative prognostic influence in certain subtypes of primary cutaneous T cell lymphomas.
Valencak J; Schmid K; Trautinger F; Wallnöfer W; Muellauer L; Soleiman A; Knobler R; Haitel A; Pehamberger H; Raderer M
J Dermatol Sci; 2011 Dec; 64(3):185-90. PubMed ID: 21937200
[TBL] [Abstract][Full Text] [Related]
12. Cutaneous T-cell lymphoma-associated lung cancers show chromosomal aberrations differing from primary lung cancer.
Hahtola S; Burghart E; Puputti M; Karenko L; Abdel-Rahman WM; Väkevä L; Jeskanen L; Virolainen S; Karvonen J; Salmenkivi K; Kinnula V; Joensuu H; Peltomäki P; Klein CA; Ranki A
Genes Chromosomes Cancer; 2008 Feb; 47(2):107-17. PubMed ID: 17985357
[TBL] [Abstract][Full Text] [Related]
13. Increased CCL18 expression in patients with cutaneous T-cell lymphoma: association with disease severity and prognosis.
Miyagaki T; Sugaya M; Suga H; Ohmatsu H; Fujita H; Asano Y; Tada Y; Kadono T; Sato S
J Eur Acad Dermatol Venereol; 2013 Jan; 27(1):e60-7. PubMed ID: 22404649
[TBL] [Abstract][Full Text] [Related]
14. A suggested protocol for obtaining high-quality skin metaphases from primary cutaneous T-cell lymphoma.
Chevret E; Prochazkova M; Beylot-Barry M; Merlio JP
Cancer Genet Cytogenet; 2006 May; 167(1):89-91. PubMed ID: 16682294
[No Abstract] [Full Text] [Related]
15. IL-22, but not IL-17, dominant environment in cutaneous T-cell lymphoma.
Miyagaki T; Sugaya M; Suga H; Kamata M; Ohmatsu H; Fujita H; Asano Y; Tada Y; Kadono T; Sato S
Clin Cancer Res; 2011 Dec; 17(24):7529-38. PubMed ID: 22048239
[TBL] [Abstract][Full Text] [Related]
16. Spectral karyotyping demonstrates genetically unstable skin-homing T lymphocytes in cutaneous T-cell lymphoma.
Padilla-Nash HM; Wu K; Just H; Ried T; Thestrup-Pedersen K
Exp Dermatol; 2007 Feb; 16(2):98-103. PubMed ID: 17222222
[TBL] [Abstract][Full Text] [Related]
17. Detergent fractionation with subsequent subtractive suppression hybridization as a tool for identifying genes coding for plasma membrane proteins.
Lange A; Kistler C; Jutzi TB; Bazhin AV; Klemke CD; Schadendorf D; Eichmüller SB
Exp Dermatol; 2009 Jun; 18(6):527-35. PubMed ID: 19175411
[TBL] [Abstract][Full Text] [Related]
18. Histopathology and genetics of cutaneous T-cell lymphoma.
Smoller BR; Santucci M; Wood GS; Whittaker SJ
Hematol Oncol Clin North Am; 2003 Dec; 17(6):1277-311. PubMed ID: 14710885
[TBL] [Abstract][Full Text] [Related]
19. The mutational landscape of cutaneous T cell lymphoma and Sézary syndrome.
da Silva Almeida AC; Abate F; Khiabanian H; Martinez-Escala E; Guitart J; Tensen CP; Vermeer MH; Rabadan R; Ferrando A; Palomero T
Nat Genet; 2015 Dec; 47(12):1465-70. PubMed ID: 26551667
[TBL] [Abstract][Full Text] [Related]
20. Cutaneous T cell lymphoma: the helping hand of dendritic cells.
Edelson RL
Ann N Y Acad Sci; 2001 Sep; 941():1-11. PubMed ID: 11594563
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
